DiscoverCReATe PodcastCReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS
CReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS

CReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS

Update: 2025-02-18
Share

Description

Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami.  Here he discusses the recent publication “Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis”.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

CReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS

CReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS

CReATe Consortium